NEW YORK, Feb. 3 (GenomeWeb News) - San Diego State University, Invitrogen, Pfizer, and CardioDynamics are teaming up to establish a joint PhD-MBA program in the life sciences, Invitrogen said today.
The aim is to educate studies in scientific research as well as the business of biotechnology. The program is poised to expand from a two-student pilot program that SDSU launched last September. SDSU offers the PhD part of the program in conjunction with the University of California, San Diego.
Invitrogen, Pfizer, and CardioDynamics are funding the startup phase of the program. In addition, Carlsbad, Calif.-based Invitrogen offers students lectures, case studies, and internships.
At the moment, SDSU is trying to raise additional funding for the program.